T cells could be the key in developing an effective COVID-19 vaccine
Many have embraced and the possibility of immunity to COVID-19 as the key to reopening society and the economy. Serology testing — also known as antibody testing — can indicate whether someone is producing an immune response to the virus.
But we still do not know whether the presence of antibodies in recovered patients holds promise for long-lasting immunity. Insight from immunological studies on recovered SARS patients infected in 2003 showed that antibody levels wane after just . A different immune response caused by T cells provides long term protection, even .
Based on this data, it is likely that T cell responses play a substantial role in developing protective immunity against SARS-CoV-2, the virus that causes COVID-19. There are of T cells: helper and killer T cells. When they recognize a virus, helper T cells signal to activate other types of immune cells, while killer T cells release molecules that destroy the virus.
In a , researchers at the La Jolla Institute for Immunology identified viral protein pieces in SARS-CoV-2 that are already known to induce T cell immune responses. They then exposed the immune cells from 10 recovered COVID-19 patients to these protein pieces and measured the T cell immune responses.
All of the patients had helper T cells that recognized the main SARS-CoV-2 spike protein, and about 70% of them also had killer T cells that recognized the spike and membrane proteins. The main target of the is the antibody response to the spike protein, but this new understanding of the T cell response could provide new and potentially better targets.
The mission to make a vaccine against COVID-19 is possibly the most urgent public health problem in the world today. The encouraging results in both the similarities in immune response to SARS and SARS-CoV-2 and the identification of strong T cell responses in recovered COVID-19 patients promote further research in designing vaccines to induce T cell responses.
This story originally appeared on , an editorial partner site that publishes science stories by scientists. to get even more science sent straight to you.

Enjoy reading 91亚色传媒 Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91亚色传媒 Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Targeting toxins to treat whooping cough
Scientists find that liver protein inhibits of pertussis toxin, offering a potential new treatment for bacterial respiratory disease. Read more about this recent study from the Journal of Biological Chemistry.

Elusive zebrafish enzyme in lipid secretion
Scientists discover that triacylglycerol synthesis enzyme drives lipoproteins secretion rather than lipid droplet storage. Read more about this recent study from the Journal of Biological Chemistry.

Scientists identify pan-cancer biomarkers
Researchers analyze protein and RNA data across 13 cancer types to find similarities that could improve cancer staging, prognosis and treatment strategies. Read about this recent article published in Molecular & Cellular Proteomics.

New mass spectrometry tool accurately identifies bacteria
Scientists develop a software tool to categorize microbe species and antibiotic resistance markers to aid clinical and environmental research. Read about this recent article published in Molecular & Cellular Proteomics.

New tool matches microbial and metabolic metaproteomic data
Scientists develop a bioinformatics program that maps omics data to metabolic pathways. Read about this recent article published in Molecular & Cellular Proteomics

Meet Paul Shapiro
Learn how the JBC associate editor went from milking cows on a dairy farm to analyzing kinases in the lab.